Among characteristics examined, relative survival varied most by stage at diagnosis: the 5-year relative survival for males was higher for cancers diagnosed at localized stage (98.7%) than for those diagnosed at distant stage (25.9%). Among males who received a diagnosis of breast cancer during 2007–2016, 1-year relative survival was 96.1%, and 5-year relative survival was 84.7%. CDC’s National Program of Cancer Registries (NPCR) † data were used to examine relative survival of males with breast cancer diagnosed during 2007–2016 by race/ethnicity, age group, stage at diagnosis, and U.S. Studies examining survival differences among female breast cancer patients observed that non-Hispanic White (White) females had a higher survival than non-Hispanic Black (Black) females ( 2), but because of the rarity of breast cancer among males, few studies have examined survival differences by race or other factors such as age, stage, and geographic region. Gradual improvement in breast cancer survival from 1976–1985 to 1996–2005 has been more evident for women than for men ( 1).
Breast cancer among males in the United States is rare approximately 2,300 new cases and 500 associated deaths were reported in 2017, accounting for approximately 1% of all breast cancers.* Risk for male breast cancer increases with increasing age ( 1), and compared with women, men receive diagnoses later in life and often at a later stage of disease ( 1).
0 kommentar(er)
